Literature DB >> 27776374

Investigation of Mammal Arginase Inhibitory Properties of Natural Ubiquitous Polyphenols by Using an Optimized Colorimetric Microplate Assay.

Simon Bordage1, Thanh-Nhat Pham1, Andy Zedet1, Anne-Sophie Gugglielmetti1, Maude Nappey1, Céline Demougeot1, Corine Girard-Thernier1.   

Abstract

Polyphenols are plant secondary metabolites which possess many positive effects on human health. Although these beneficial effects could be mediated through an increase in nitric oxide synthase activity, little is known regarding the inhibitory effect of polyphenols on mammal arginase, an enzyme which competes with nitric oxide synthase for their common substrate, L-arginine. The aim of the present study was to determine the potential of a series of polyphenols as mammalian arginase inhibitors and to identify some structure-activity relationships. For this purpose, we first developed a simple and cost-effective in vitro colorimetric microplate method using commercially-available mammal bovine liver arginase (b-ARG 1). Among the ten tested polyphenolic compounds [chlorogenic acid, piceatannol, resveratrol, (-)-epicatechin, taxifolin, quercetin, fisetin, caffeic acid, quinic acid, and kaempferol], cholorogenic acid and piceatannol exhibited the highest inhibitory activities (IC50 = 10.6 and 12.1 µM, respectively) but were however less active as (S)-(2-Boronoethyl)-L-cysteine (IC50 = 3.3 µM), used as reference compound. Enzyme kinetic studies showed that both chlorogenic acid and piceatannol are competitive arginase inhibitors. Structural data identified the importance of the caffeoyl (3,4-dihydroxycinnamoyl)-part and of the catechol function in the inhibitory activity of the tested compounds. These results identified chlorogenic acid and piceatannol as two potential core structures for the design of new arginase inhibitors. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27776374     DOI: 10.1055/s-0042-118711

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  9 in total

1.  Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors.

Authors:  J Muller; B Cardey; A Zedet; C Desingle; M Grzybowski; P Pomper; S Foley; D Harakat; C Ramseyer; C Girard; M Pudlo
Journal:  RSC Med Chem       Date:  2020-04-17

Review 2.  Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective.

Authors:  Gonçalo S Clemente; Aren van Waarde; Inês F Antunes; Alexander Dömling; Philip H Elsinga
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

Review 3.  Natural Products That Target the Arginase in Leishmania Parasites Hold Therapeutic Promise.

Authors:  Nicola S Carter; Brendan D Stamper; Fawzy Elbarbry; Vince Nguyen; Samuel Lopez; Yumena Kawasaki; Reyhaneh Poormohamadian; Sigrid C Roberts
Journal:  Microorganisms       Date:  2021-01-28

4.  The chemical constituents of Sterculia comosa (wall) Roxb woods for arginase inhibitory, antioxidant activity, and molecular docking against SARS CoV-2 protein.

Authors:  Rini Prastiwi; Berna Elya; Muhammad Hanafi; Rani Sauriasari; Yesi Desmiaty; Ema Dewanti; Rina Herowati
Journal:  Heliyon       Date:  2022-01-19

5.  Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2.

Authors:  Trishna Saha Detroja; Abraham O Samson
Journal:  Molecules       Date:  2022-08-12       Impact factor: 4.927

Review 6.  Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases.

Authors:  Zhuozhuo Li; Liwei Wang; Yuanyuan Ren; Yaoyao Huang; Wenxuan Liu; Ziwei Lv; Lu Qian; Yi Yu; Yuyan Xiong
Journal:  Cell Death Discov       Date:  2022-10-08

7.  Cinnamide Derivatives as Mammalian Arginase Inhibitors: Synthesis, Biological Evaluation and Molecular Docking.

Authors:  Thanh-Nhat Pham; Simon Bordage; Marc Pudlo; Céline Demougeot; Khac-Minh Thai; Corine Girard-Thernier
Journal:  Int J Mol Sci       Date:  2016-09-29       Impact factor: 5.923

8.  Cinnamides Target Leishmania amazonensis Arginase Selectively.

Authors:  Edson Roberto da Silva; Júlio Abel Alfredo Dos Santos Simone Come; Simone Brogi; Vincenzo Calderone; Giulia Chemi; Giuseppe Campiani; Trícia Maria Ferrreira de Sousa Oliveira; Thanh-Nhat Pham; Marc Pudlo; Corine Girard; Claudia do Carmo Maquiaveli
Journal:  Molecules       Date:  2020-11-12       Impact factor: 4.411

Review 9.  Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies.

Authors:  Iveta Bernatova; Silvia Liskova
Journal:  Antioxidants (Basel)       Date:  2021-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.